Correlation Between PsyBio Therapeutics and Oxford Cannabinoid

Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and Oxford Cannabinoid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and Oxford Cannabinoid into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PsyBio Therapeutics Corp and Oxford Cannabinoid Technologies, you can compare the effects of market volatilities on PsyBio Therapeutics and Oxford Cannabinoid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of Oxford Cannabinoid. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and Oxford Cannabinoid.

Diversification Opportunities for PsyBio Therapeutics and Oxford Cannabinoid

-1.0

Correlation Coefficient

PsyBio Therapeutics  Oxford Cannabinoid

Pay attention - limited upside

The 3 months correlation between PsyBio and Oxford is -1.0. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and Oxford Cannabinoid Technologie in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oxford Cannabinoid and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with Oxford Cannabinoid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oxford Cannabinoid has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and Oxford Cannabinoid go up and down completely randomly.

Pair Corralation between PsyBio Therapeutics and Oxford Cannabinoid

If you would invest  0.28  in Oxford Cannabinoid Technologies on December 26, 2024 and sell it today you would earn a total of  0.00  from holding Oxford Cannabinoid Technologies or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

PsyBio Therapeutics Corp  vs.  Oxford Cannabinoid Technologie

PsyBio Therapeutics Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days PsyBio Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, PsyBio Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Oxford Cannabinoid

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oxford Cannabinoid Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Oxford Cannabinoid is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with PsyBio Therapeutics and Oxford Cannabinoid

The main advantage of trading using opposite PsyBio Therapeutics and Oxford Cannabinoid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, Oxford Cannabinoid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oxford Cannabinoid will offset losses from the drop in Oxford Cannabinoid's long position.

The idea behind PsyBio Therapeutics Corp and Oxford Cannabinoid Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.